<HashMap><database>MetabolomicsWorkbench</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>http://www.metabolomicsworkbench.org/rest/study/study_id/ST000862/mwtab</Other></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Metabolomics</omics_type><technology_type>Mass Spectrometry</technology_type><technology_type>ESI</technology_type><disease>Spinal Cord Injury</disease><species>Mus Musculus</species><full_dataset_link>http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&amp;StudyID=ST000862</full_dataset_link><study_factor>time:P60 | group:CTRL</study_factor><study_factor>time:P21 | group:CTRL</study_factor><study_factor>time:P60 | group:PAR1</study_factor><study_factor>time:P60 | group:PAR2</study_factor><study_factor>time:P21 | group:PAR1</study_factor><study_factor>time:P21 | group:PAR2</study_factor><tissue>Spinal Cord</tissue><submitter_affiliation>Mayo Clinic</submitter_affiliation><sample_protocol>HILIC NEGATIVE ION MODE.</sample_protocol><repository>MetabolomicsWorkbench</repository><metabolite_name>linoleic</metabolite_name><metabolite_name>arachidonic</metabolite_name><metabolite_name>linolenic</metabolite_name><metabolite_name>trans-palmitoleic</metabolite_name><metabolite_name>stearic</metabolite_name><metabolite_name>cis-oleic</metabolite_name><metabolite_name>myristic</metabolite_name><metabolite_name>trans-oleic</metabolite_name><metabolite_name>EPA</metabolite_name><metabolite_name>palmitic</metabolite_name><metabolite_name>DHA</metabolite_name><metabolite_name>cis-palmitoleic</metabolite_name><data_protocol></data_protocol><name_synonyms>pbp2, acidum flufenamicum, 3.4.22.-, F7D19.13, Laboratory, f2r-a, Mus domesticus, mini-ICE, CASP-14, flufenamic acid, DmelCG8201, ONR1, CF2R, House Mouse, F7D19_13, House, dPAR-1, D15Ertd747e, Mus musculus domesticus, PARq, dPar-1, GPCR42, Mice, 27C1, Gpr172b, N-(alpha, PXR, Swiss, l(2)k06323, Swiss Mice, mRFT1, Cf2r, par-1, PAR-2, HELIX-LOOP-HELIX 1, PAR-1, emk-1, GPR11, emk-2, Par-1, Par-2, Myelin Sheaths, CG16701, PHY RAPIDLY REGULATED 1, TR, FFA, PAR, par1, CG8201, acide flufenamique, SXR, Sheath, PRR, CASP14, mouse, dPAR1, dPar1, ThrR, dMARK, 3'-trifluoromethyldiphenylamine-2-carboxylic acid, AI482343, CG11960, ctak1, CG30131, CG30132, EMK, Mus, anon-WO0210402.19, DPAR-1, Mini-ICE, Achless, fluphenamic acid, SNQ3, Mus musculus., BXR, alpha-trifluoro-m-tolyl)anthranilic acid, acido flufenamico, Mus musculus, SAR, Flufenaminsaeure, HTR, Caspase-14 subunit p10, HLH1, mice, Swiss Mouse, Sheaths, House Mice, Caspase-14 subunit p19, alpha, Gpcr11, MICE, c-tak1, Laboratory Mice, domesticus, N-(3-trifluoromethylphenyl)anthranilic acid, emk1, Myelin, l(2)27C1, 2-[3-(trifluoromethyl)anilino]benzoic acid, BcDNA:RH48823, par1b, 2010003P03Rik, MARK, DPar1, Par-1A, PAR2, Par2, Mouse, PAR1, Par1, Laboratory Mouse, 2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID</name_synonyms><sample_synonyms>iones., Ionen, ion, Ion, ions</sample_synonyms></additional><is_claimable>false</is_claimable><name>Targeting Myelin FFA Compostion in PAR1 and PAR2 Mice after SCI</name><description/><dates><publication></publication></dates><accession>ST000862</accession><cross_references><TAXONOMY>10090</TAXONOMY></cross_references></HashMap>